Republic Republic Republic
  • Log in
Open account
Oops! We couldn’t find any results...
Can’t find a deal? Try advanced search.
Is something missing? Add your suggestion here.
Primary market Live deals Trading Buy and sell Republic Note Own a piece of Republic's upside
Republic Ventures Opportunities for accredited investors
Republic Capital Multi-stage venture firm
Wallet Manage your digital assets Mobile app Available on iOS or Android Learning center Explore investor resources FAQ Get your questions answered
Capital fundraising Raise on Republic Tokenized assets Design, launch, manage tokenized assets Sharedrops Gift equity as a reward Founder Academy A complete guide to raising funds
Advisory Access veteran web3 advisors Infrastructure Stake your digital assets Tokenization Deploy your assets on-chain
Republic Capital In-house Venture Capital fund Broker dealer Regulated capital services
Republic Republic Republic
Oops! We couldn’t find any results...
Can’t find a deal? Try advanced search.
Is something missing? Add your suggestion here.
  • US

  • Log in
  • Open account
All investors
Primary market Live deals Trading Buy and sell
Republic Note Own a piece of Republic's upside
Accredited only
Republic Ventures Opportunities for accredited investors
Institutional
Republic Capital Multi-stage venture firm
More
Wallet Manage your digital assets Mobile app Available on iOS or Android Learning center Explore investor resources FAQ Get your questions answered
Growth capital solutions
Capital fundraising Raise on Republic Tokenized assets Design, launch, manage tokenized assets Sharedrops Gift equity as a reward Founder Academy A complete guide to raising funds
Web3 services
Advisory Access veteran web3 advisors Infrastructure Stake your digital assets
Tokenization Deploy your assets on-chain
Institutional services
Republic Capital In-house Venture Capital fund
Broker dealer Regulated capital services

Orthosnap isn't accepting new investments

Orthosnap’s deadline was September 8, 2022

Follow the company to stay updated on their progress, including future investment opportunities


Explore new investment opportunities:
View companies raising now
Campaign ended
Logo of Orthosnap

Orthosnap

Venture and dentist-backed clear aligner company
Wellness Healthcare
Facebook Telegram Twitter LinkedIn
Featured image of Orthosnap
This is an SPV deal. See fees.
Round
Series A
Valuation
$20M
Minimum investment
$3,500
Instrument
Preferred Equity
Deadline
September 8, 2022
Invest in Orthosnap

Open for investment

Investors in Orthosnap also invested in these companies. View more
Logo of  Metaintro

Metaintro

The Bloomberg of Labor Markets - AI-powered workforc...

Republic Funding Portal · Reg CF
Loading...
Co-investors
Loeb.nyc
Investors in Mercato, Payoneer, Popwallet
Loeb NYC is a startup lab and early-stage private investor built on the belief that aligning the right people with the right ideas creates successful companies. They are entrepreneurs, strategic partners, mentors, and industry experts who have launched and scaled enduring companies across industries utilizing proven strategies and techniques.
Pitch Updates 2
Questions? (855)-668-2575
Invest Invest in Orthosnap
Questions?
Facebook Telegram Twitter LinkedIn
Closed on September 8, 2022. Information may not be up-to-date. Campaign closed on September 8, 2022. Information displayed may not be up-to-date.
Problem Solution Product Traction Customers Biz. model Market Competition Vision and strategy Funding Founders Disclaimers

Documents

Republic Deal Room Advisor (Republic Deal Room Advisor LLC, CRD# 31568) is hosting this Reg D 506(c) securities offering by Orthosnap I, A Series of Republic Deal Room Master Fund, LP.
Company documents
Subscription Agreement Orthosnap I PPM.pdf Orthosnap I LPA.pdf
Loading

Investment summary


Venture-backed
Company is backed by a venture capital firm

The market for orthodontics in the US is large, with any player capturing even just 1% of market shares standing to make $100M in yearly revenue. Orthosnap stands out from the crowd by structuring their cost structure to incentivize dentists, while providing a product 40% less expensive than competitors due to their patented manufacturing process. The Company claims their solution has more predictable outcomes, with fewer refinements, attachments, and chair time.

This is a special purpose vehicle formed to invest in the Series A Round of Orthosnap, led by Loeb.nyc.

Investment highlights (provided by the Company as of June 2022):

  • Patented manufacturing delivers cheaper, faster & better aligners
  • Industry-leading treatment plan & advanced proprietary software
  • Customer traction: 1.4K+ dentist offices
  • $2.1M contracted revenue in 2021, estimated 3.4M by EOY
  • Currently utilizing 33% of 6k unit per month capacity
  • Advised by founder of 1-800-Dentist & Priceline.com

Problem


75% of the world population has malocclusions
(crooked teeth)

But today's clear aligner solutions aren't meeting the needs of consumers or dentists.


Consumer paradox


Consumers cannot assure quality and safety or determine essential touchpoints like evaluations, attachments and interproximal reduction.


Dentist problem


Dentists are losing patient relationships to cheap DTC alternatives that are using undifferentiated products.


Other issues in today's aligner market


Solution


Why Orthosnap wins

Dentists want the combination of DTC price + B2B quality. 


Orthosnap's patented manufacturing dramatically reduces the cost of orthodontic care while providing the highest quality aligner system to dental professionals.

Product


The Orthosnap Way


  • Movement is achieved through accuracy of aligner fit combined with staged segmented movements.
  • Analog / imprint methodology provides increased accuracy & leading results vs current market incumbents.

—

Orthosnap is set apart by our industry-leading treatment plan and advanced proprietary software

Traction


$2.1M contracted
revenue in 2021





Financial forecast


Customers


Dentists want the combination of DTC price + B2B quality

Dentists can significantly impact the industry by providing the highest quality aligner system to customers.

Orthosnap patented manufacturing dramatically reduces the cost of orthodontic care.

Business model


Scalable / data-centric manufacturing

  • 10K sq ft production facility in New York
  • Currently 33% utilization of 6,000 aligners / month capacity
  • Each technician adds capacity to produce 1,000 aligners / month
  • Incremental automation potential for margin improvement

Market


Aesthetics and affordability are increasing demand for cosmetic teeth correction,

driving a 23% CAGR in the past decade to $7.5B+ in 2027.

1% market share yields $100M+ in revenue

Competition


Dentists can generate an incremental 20% margin compared to Invisalign

Orthosnap’s cost structure provides dentists with more cash flow with pay-as-you-go, flexible step pricing.

—
Dentists acquire More Patients

Dentists can offer more affordable patient prices without sacrificing margins, expanding the market, and capture significant share from DTC, while improving quality and health outcomes.



Unique Competitive Advantages



Competitive Landscape


Vision and strategy


Trusted by dentists.
Loved by patients.

—
Our Vision

“To strengthen the bond between dentists and patients throughout the world”.

—
Our Mission

“To empower every dentist to create beautiful smiles for each patient, through innovative technology, world-class support, and affordable care”.

Funding


Raise & use of proceeds


Founders


The Orthosnap team


Advisory team


Disclaimers


In addition to the carried interest Republic Deal Room Advisor LLC is entitled to for the syndicated investments it organizes, certain principals of Republic Deal Room Advisor LLC may have a personal interests in these investments, as disclosed below. When making an investment decision please review any applicable disclosures as they represent pre-existing financial interests held by those principals of Republic Deal Room Advisor LLC.

We do not represent that the information contained herein is accurate or complete, and it should not be relied upon as such. Opinions expressed herein are subject to change without notice. Certain information contained herein (including any forward-looking statements and economic and market information) has been obtained from and/or prepared by the Company or other third-party sources and in certain cases has not been updated through the date hereof. While such sources are believed to be reliable, Republic Deal Room Advisor LLC does not assume any responsibility for the accuracy or completeness of such information. Republic Deal Room Advisor LLC does not undertake any obligation to update the information contained herein as of any future date.

Documents

Republic Deal Room Advisor (Republic Deal Room Advisor LLC, CRD# 31568) is hosting this Reg D 506(c) securities offering by Orthosnap I, A Series of Republic Deal Room Master Fund, LP.
Company documents
Subscription Agreement Orthosnap I PPM.pdf Orthosnap I LPA.pdf
Logo of Orthosnap

Orthosnap

Orthosnap successfully raised $69,500 from 16 investors on September 8, 2022
Republic

Giving everyone access to early-stage startup investing

For investors
  • Why invest
  • How it works
  • FAQ
  • Risks
  • Privacy policy
  • Accessibility
  • Cookie Preferences
  • Form CRS
For startups
  • Why raise
  • Learn
  • FAQ
  • Tokenized assets
Company
  • About
  • Insights
  • Events
  • Contact
  • Security
  • We're hiring!
Dollar Refer a startup, get $2,500
Dollar Refer a startup, get $2,500

Invest in the app

Android app iOS app

Invest in the app

Android app iOS app

This site (the "Site") is owned by OpenDeal Inc. and hosted by its wholly owned subsidiary Republic Core LLC, a technology services provider which is not a registered broker-dealer, investment adviser, or securities intermediary. Neither Republic Core LLC nor OpenDeal Inc. provide investment advice, endorsement, analysis, or recommendations with respect to any securities. All securities listed here are being offered by, and all information included on this Site is the responsibility of, the applicable issuer of such securities. The intermediary facilitating the offering will be identified in such offering’s documentation. Certain pages discussing the mechanics and providing educational materials may refer to OpenDeal Inc. and its affiliates collectively as “Republic”, solely for explanatory purposes.

This page and all other pages that are branches are maintained by Republic Deal Room Advisor LLC, an exempt reporting investment adviser, which is a subsidiary of OpenDeal Inc. Republic Deal Room Advisor LLC may cancel an offering for any reason, and there is no guarantee that a specific allocation will be made available. Successful offerings are syndicated through a special purpose funds, and Republic Deal Room Advisor LLC or an affiliate will charge a carried interest and management fee as an investment advisor to the relevant fund. Early stage investing is highly risky and subject to total loss of capital, and is suitable for experienced investors only. Investors co-investing in Republic Deal Room Advisor LLC's syndicates are responsible for making their own investment decisions. Republic Deal Room Advisor LLC provides investment advisory services to its investment funds only.

By accessing links to other pages on the Site and thereby accessing the Site and any pages thereof, you agree to be bound by the Republic Deal Room Advisor LLC's Terms of Use and Privacy Policy, please also see Republic Deal Room Advisor LLC's Form ADV.

Investors should verify any issuer information they consider important before making an investment.

Invest in startups using your credit card
You can invest using your credit card

Made in SF/NYC